semaglutide for liver disease FDA Approval Expands Novo Nordisk's Wegovy to the Fatty MASH Severe liver disease reversed with

This biomechanical relief can lead to meaningful improvements in osteoarthritis symptoms and physical function over time

Ozempic (Semaglutide for Diabetes) Available in South Africa since 2019 Approved use: Type 2 diabetes management Dosage: Lower doses (up to 1 mg once weekly in SA, higher doses like 2 mg in some markets) Average weight loss: 10-20% of body weight in clinical trials Other benefits: Improves blood sugar control, lowers HbA1c, reduces cardiovascular risks in diabetics In South Africa, Ozempic is not officially approved for weight loss , though some doctors prescribe it off-label to help with obesity

This is why understanding eligibility criteria, particularly concerning medications, is so important for those who wish to contribute

These predispositions do not determine exact outcomes but may provide context for provider conversations about expected efficacy ranges

But in practice